Gw&K Investment Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Gw&K Investment Management, LLC

$11.7 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$144.95 - $152.29 $112,481 - $118,177	-776 Reduced 87.0%	116 $18,000
Q2 2022 Aug 09, 2022	SELL	$83.14 - $145.99 $33.7 Million - $59.2 Million	-405,364 Reduced 99.78%	892 $130,000
Q1 2022 May 09, 2022	BUY	$110.08 - $142.92 $2.84 Million - $3.69 Million	25,819 Added 6.79%	406,256 $48.2 Million
Q4 2021 Feb 11, 2022	BUY	$99.73 - $148.48 $30.2 Million - $44.9 Million	302,679 Added 389.26%	380,437 $52.4 Million
Q3 2021 Nov 10, 2021	SELL	$98.85 - $138.91 $2.53 Million - $3.56 Million	-25,606 Reduced 24.77%	77,758 $10.8 Million
Q2 2021 Aug 10, 2021	SELL	$65.78 - $105.02 $154,451 - $246,586	-2,348 Reduced 2.22%	103,364 $10 Million
Q1 2021 May 11, 2021	BUY	$64.07 - $91.75 $294,721 - $422,050	4,600 Added 4.55%	105,712 $7.23 Million
Q4 2020 Feb 05, 2021	SELL	$65.07 - $98.24 $1.19 Million - $1.79 Million	-18,228 Reduced 15.27%	101,112 $8.67 Million
Q3 2020 Nov 10, 2020	BUY	$59.04 - $77.95 $1.38 Million - $1.82 Million	23,299 Added 24.26%	119,340 $7.76 Million
Q2 2020 Aug 06, 2020	SELL	$29.01 - $74.23 $1.04 Million - $2.67 Million	-35,996 Reduced 27.26%	96,041 $7.02 Million
Q1 2020 May 11, 2020	SELL	$27.51 - $57.29 $220,327 - $458,835	-8,009 Reduced 5.72%	132,037 $4.49 Million
Q4 2019 Feb 10, 2020	SELL	$40.86 - $57.65 $258,643 - $364,924	-6,330 Reduced 4.32%	140,046 $7.62 Million
Q3 2019 Nov 05, 2019	BUY	$37.38 - $49.47 $1.6 Million - $2.12 Million	42,896 Added 41.45%	146,376 $6.11 Million
Q2 2019 Aug 06, 2019	SELL	$39.79 - $67.01 $47,708 - $80,344	-1,199 Reduced 1.15%	103,480 $4.53 Million
Q1 2019 May 14, 2019	SELL	$34.52 - $53.29 $573,964 - $886,052	-16,627 Reduced 13.71%	104,679 $5.39 Million
Q4 2018 Feb 07, 2019	BUY	$29.75 - $42.9 $3.61 Million - $5.2 Million	121,306 New	121,306 $4.49 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.

Account